Cargando…

Identification of Urine Biomarkers to Improve Eligibility for Prostate Biopsy and Detect High-Grade Prostate Cancer

SIMPLE SUMMARY: The screening of prostate cancer (PCa), based on the serum prostate specific antigen (PSA), is characterized by a high number of false positives, leading to overdiagnosis of healthy men and overtreatment of indolent PCa. This clinical problem severely affects the quality of life of p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alijaj, Nagjie, Pavlovic, Blaz, Martel, Paul, Rakauskas, Arnas, Cesson, Valérie, Saba, Karim, Hermanns, Thomas, Oechslin, Pascal, Veit, Markus, Provenzano, Maurizio, Rüschoff, Jan H., Brada, Muriel D., Rupp, Niels J., Poyet, Cédric, Derré, Laurent, Valerio, Massimo, Banzola, Irina, Eberli, Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909910/ https://www.ncbi.nlm.nih.gov/pubmed/35267445 http://dx.doi.org/10.3390/cancers14051135

Ejemplares similares

Infiltrative growth pattern of prostate cancer is associated with lower uptake on PSMA PET and reduced diffusion restriction on mpMRI
por: Laudicella, Riccardo, et al.
Publicado: (2022)

Negative LC3b immunoreactivity in cancer cells is an independent prognostic predictor of prostate cancer specific death
por: Mortezavi, Ashkan, et al.
Publicado: (2017)

A curated collection of tissue microarray images and clinical outcome data of prostate cancer patients
por: Zhong, Qing, et al.
Publicado: (2017)

Prostate cancer detection rate in men undergoing transperineal template‐guided saturation and targeted prostate biopsy
por: Kaufmann, Basil, et al.
Publicado: (2021)

Antibody response to BK polyomavirus as a prognostic biomarker and potential therapeutic target in prostate cancer
por: Keller, Xavier Etienne, et al.
Publicado: (2015)

What’s behind (68)Ga-PSMA-11 uptake in primary prostate cancer PET? Investigation of histopathological parameters and immunohistochemical PSMA expression patterns
por: Rüschoff, Jan H., et al.
Publicado: (2021)

High VEGF-D and Low MMP-2 Serum Levels Predict Nodal-Positive Disease in Invasive Bladder Cancer
por: Benoit, Tobias, et al.
Publicado: (2015)

Immunohistochemical PSMA expression patterns of primary prostate cancer tissue are associated with the detection rate of biochemical recurrence with (68)Ga-PSMA-11-PET
por: Ferraro, Daniela A., et al.
Publicado: (2020)

Do cancer detection rates differ between transperineal and transrectal micro-ultrasound mpMRI-fusion-targeted prostate biopsies? A propensity score-matched study
por: Rakauskas, Arnas, et al.
Publicado: (2023)

Implication of vascular endothelial growth factor A and C in revealing diagnostic lymphangiogenic markers in node-positive bladder cancer
por: Poyet, Cédric, et al.
Publicado: (2017)

Automated Gleason grading of prostate cancer tissue microarrays via deep learning
por: Arvaniti, Eirini, et al.
Publicado: (2018)

Quantitative imaging parameters to predict the local staging of prostate cancer in intermediate- to high-risk patients
por: Laudicella, Riccardo, et al.
Publicado: (2022)

Author Correction: Automated Gleason grading of prostate cancer tissue microarrays via deep learning
por: Arvaniti, Eirini, et al.
Publicado: (2019)

Author Correction: Automated Gleason grading of prostate cancer tissue microarrays via deep learning
por: Arvaniti, Eirini, et al.
Publicado: (2021)

Focal Therapy for Prostate Cancer: Complications and Their Treatment
por: Rakauskas, Arnas, et al.
Publicado: (2021)

Modified Immunoscore Improves Prediction of Survival Outcomes in Patients Undergoing Radical Cystectomy for Bladder Cancer—A Retrospective Digital Pathology Study
por: Bieri, Uwe, et al.
Publicado: (2022)

Oxygen supply maps for hypoxic microenvironment visualization in prostate cancer
por: Rupp, Niels J., et al.
Publicado: (2016)

Prognostic value of pretreatment inflammatory markers in localised prostate cancer before radical prostatectomy
por: Grogg, Josias Bastian, et al.
Publicado: (2023)

The proprotein convertase furin is required to maintain viability of alveolar rhabdomyosarcoma cells
por: Jaaks, Patricia, et al.
Publicado: (2016)

Automated prediction of dosimetric eligibility for hypofractionated prostate radiotherapy
por: Lausch, Anthony, et al.
Publicado: (2017)

Prostate Cancer Care Before and After Medicare Eligibility
por: Huesch, Marco D., et al.
Publicado: (2016)

Therapy decisions after diagnosis of prostate cancer in men with negative prostate MRI
por: Schmid, Florian A., et al.
Publicado: (2022)

Comprehensive immunohistochemical analysis of PD-L1 shows scarce expression in castration-resistant prostate cancer
por: Fankhauser, Christian D., et al.
Publicado: (2017)

Can quantitative analysis of multi-parametric MRI independently predict failure of focal salvage HIFU therapy in men with radio-recurrent prostate cancer?
por: Rakauskas, Arnas, et al.
Publicado: (2021)

Convergent network effects along the axis of gene expression during prostate cancer progression
por: Charmpi, Konstantina, et al.
Publicado: (2020)

Phenotype and Reactivity of Lymphocytes Expanded from Benign Prostate Hyperplasic Tissues and Prostate Cancer
por: Ahmed, Ritaparna, et al.
Publicado: (2023)

Comparative analysis of mRNA and protein degradation in prostate tissues indicates high stability of proteins
por: Shao, Wenguang, et al.
Publicado: (2019)

Prostate Health Index and Prostate Health Index Density as Diagnostic Tools for Improved Prostate Cancer Detection
por: Barisiene, Marija, et al.
Publicado: (2020)

Single-cell proteomics defines the cellular heterogeneity of localized prostate cancer
por: De Vargas Roditi, Laura, et al.
Publicado: (2022)

Can Metabolic Disorders in Aging Men Contribute to Prostatic Hyperplasia Eligible for Transurethral Resection of the Prostate (TURP)?
por: Rył, Aleksandra, et al.
Publicado: (2015)

Active surveillance in males with low- to intermediate-risk localized prostate cancer: A modern prospective cohort study
por: Rakauskas, Arnas, et al.
Publicado: (2021)

Assessing cancer risk in the anterior part of the prostate using micro-ultrasound: validation of a novel distinct protocol
por: Schaer, Sandy, et al.
Publicado: (2023)

Pathological upgrading in prostate cancer patients eligible for active surveillance: Does prostate-specific antigen density matter?
por: Jin, Byung-Soo, et al.
Publicado: (2015)

Modified immunoscore improves the prediction of progression-free survival in patients with non-muscle-invasive bladder cancer: A digital pathology study
por: Bieri, Uwe, et al.
Publicado: (2022)

Expression of Indoleamine 2,3-Dioxygenase Induced by IFN-γ and TNF-α as Potential Biomarker of Prostate Cancer Progression
por: Banzola, Irina, et al.
Publicado: (2018)

Oncological and functional outcomes after testis-sparing surgery in patients with germ cell tumors: a systematic review of 285 cases
por: Grogg, Josias Bastian, et al.
Publicado: (2022)

The Role of Additional Epididymis Resection during Hydrocelectomy: Is It of Any Benefit in Comparison to Simple Hydrocelectomy?
por: Grossmann, Nico C., et al.
Publicado: (2023)

Multi-region proteome analysis quantifies spatial heterogeneity of prostate tissue biomarkers
por: Guo, Tiannan, et al.
Publicado: (2018)

Impact of short‐term Dutasteride treatment on prostate‐specific membrane antigen expression in a mouse xenograft model
por: Kranzbühler, Benedikt, et al.
Publicado: (2021)

CD73 Predicts Favorable Prognosis in Patients with Nonmuscle-Invasive Urothelial Bladder Cancer
por: Wettstein, Marian S., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_72nas6ql128gnokgm0n2jusv08